声明
摘要
ABSTRACT
PREFACE
TABLE OF CONTENTS
ABBREVIATIONS
PART-Ⅰ LITERATURE REVIEW Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease treated with anti-TNFα:A Meta-analysis
1.Background
2.Introduction
3.Incidence
4.Differentiation in clinical Crohn’s disease and Ulcerative colitis
5.Treatments of Inflammatory bowel disease
6.Prognosis
7.Tumor necrosis factor alpha inhibitor agents
8.Preparing for the biologic therapy
TB screening and prophylaxis
Introduction of therapy
9.Adverse etIfects of TNF-α inhibitor treatment
PART-Ⅱ Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease treated with anti-TNFα:A Meta-analysis
BACKGROUND
1.METHODOLOGY
Data collection
Inclusion/exclusion criteria
Case Selection
Quality assessment
Statistical analysis
2.RESULTS
Finding and selection results
Screening of TB and prophylaxis
Analyses the risk of latent tuberculosis infection with prophylaxis treatment and non-prophylaxis in anti TNF alpha agent therapy
Analysis of latent tuberculosis prior to anti TNFalpha agent therapy
Reactivation of LTBI after prophylactic treatment in anti TNF-α agent therapy
Publication bias and Sensitivity analysis
3.DISCUSSION
4.STUDY LIMITATIONS
5.CONCLUSION
REFERENCE
AUTHOR’S PROFILE
ACKNOWLEDGEMENTS